What is the clinical evidence from this study?

Population: Ischemia/reperfusion injury (experimental) (n=66). Intervention: Spironolactone vs. Vehicle / Control. Primary outcome: Infarct size (% of risk area) (p=<0.05).

What question did this study set out to answer?

This research aims to understand how aldosterone and spironolactone affect heart function and injury mechanisms in rats.

April 18, 2005British Journal of PharmacologyOpen Access

Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?

Q: What are the key findings of this study?

In isolated rat hearts subjected to ischemia and reperfusion, spironolactone reduced infarct size from 68% to 45% and improved left ventricular pressure recovery.

Q: What question did this study set out to answer?

This research aims to understand how aldosterone and spironolactone affect heart function and injury mechanisms in rats.

View Full Paper

Ask AI

Bookmark

Key result

In isolated rat hearts subjected to ischemia and reperfusion, spironolactone reduced infarct size from 68% to 45% and improved left ventricular pressure recovery.

Key Points

This research aims to understand how aldosterone and spironolactone affect heart function and injury mechanisms in rats.
Male Wistar rat hearts were perfused using Langendorff apparatus.
Comparison of effects of aldosterone and spironolactone to angiotensin II on left ventricular pressure and coronary flow.
Assessment of infarct size following coronary artery occlusion after treatment with spironolactone.
Spironolactone reduced infarct size from 68% to 45%, similar to preconditioning.
Aldosterone increased left ventricular pressure by 9%, reduced coronary flow by 20%, and did not affect infarct size.
Inhibition of DNA and collagen synthesis was observed with spironolactone in cardiomyocytes and fibroblasts.

Structured PICO

Population

66 male Wistar rats and cultured rat cardiac cells were used to investigate the genomic and nongenomic effects of aldosterone and spironolactone on the heart.

Intervention

Aldosterone, spironolactone, and angiotensin II (various concentrations) administered via perfusion or in culture medium.

Comparator

Vehicle (ethanol) or no treatment (control).

Outcome

Left ventricular pressure (LVP), coronary flow (CF), infarct size (% of risk area), DNA synthesis ([3H]thymidine incorporation), and collagen synthesis ([3H]proline incorporation).surrogate

Main Result

Absolute Event Rate: 45% vs 68%

p-value: p=<0.05

Spironolactone reduces infarct size and improves functional recovery after ischemia, providing a potential mechanism for its cardioprotective effects in heart failure.

Limitations

Animal and in vitro models may not fully translate to human heart failure
High concentrations of aldosterone were required to inhibit DNA and collagen synthesis in vitro
Potential physiological antagonism by the ethanol vehicle used to dissolve spironolactone

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Spironolactone may confer myocardial protection; leaves open translation from isolated rat hearts to clinical ischemia-reperfusion injury.

Cite This Study

Chai et al. (2005) studied Ischemia/reperfusion injury (experimental) (n=66). Spironolactone vs. Vehicle / Control was evaluated on Infarct size (% of risk area) (p=<0.05). In isolated rat hearts subjected to ischemia and reperfusion, spironolactone reduced infarct size from 68% to 45% and improved left ventricular pressure recovery.

synapsesocial.com/papers/6a2071daa40bcbc79e099187 https://doi.org/10.1038/sj.bjp.0706220

View Full Paper

Ask AI

Bookmark

Implication

Spironolactone may confer myocardial protection; leaves open translation from isolated rat hearts to clinical ischemia-reperfusion injury.

Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?

Key Points

Structured PICO

Main Result

Limitations

Discussion

Implication

Cite This Study

Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?

Key Points

Structured PICO

Main Result

Limitations

Discussion

Implication

Cite This Study

Also Consider

Also Consider